{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:19:59Z","timestamp":1772342399423,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.xphs.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T19:09:26Z","timestamp":1638904166000},"page":"852-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Possible Extraction of Drugs from Lung Tissue During Broncho-alveolar Lavage Suggest Uncertainty in the Procedure's Utility for Quantitative Assessment of Airway Drug Exposure"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-5566","authenticated-orcid":false,"given":"E.","family":"B\u00e4ckstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Erngren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.-M.","family":"Fihn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6112-2971","authenticated-orcid":false,"given":"M.W.","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-2417","authenticated-orcid":false,"given":"M.","family":"Frid\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Grime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.xphs.2021.12.004_bib0001","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.xphs.2021.12.004_bib0002","series-title":"Comprehensive Toxicology","first-page":"243","article-title":"In vitro systems for studying respiratory system toxicology","author":"Ballinger","year":"2010"},{"issue":"2","key":"10.1016\/j.xphs.2021.12.004_bib0003","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J Appl Physiol"},{"issue":"4","key":"10.1016\/j.xphs.2021.12.004_bib0004","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1152\/ajplegacy.1975.229.4.989","article-title":"Transalveolar transport of large polar solutes (sucrose, inulin, and dextran)","volume":"229","author":"Theodore","year":"1975","journal-title":"Am J Physiol"},{"key":"10.1016\/j.xphs.2021.12.004_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.RES.16.4.353","article-title":"Permeability of the alveolar membrane to solutes","volume":"16","author":"Taylor","year":"1965","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.xphs.2021.12.004_bib0006","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/mp300476z","article-title":"Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics","volume":"10","author":"Grime","year":"2013","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2021.12.004_bib0007","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/jps.24575","article-title":"Development of a novel lung slice methodology for profiling of inhaled compounds","volume":"105","author":"Backstrom","year":"2016","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2021.12.004_bib0008","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/j.xphs.2016.08.014","article-title":"Lung retention by lysosomal trapping of inhaled drugs can be predicted in vitro with lung slices","volume":"105","author":"Backstrom","year":"2016","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2021.12.004_bib0009","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000381117","article-title":"A unique story in neonatal research: the development of a porcine surfactant","volume":"107","author":"Curstedt","year":"2015","journal-title":"Neonatology"},{"key":"10.1016\/j.xphs.2021.12.004_bib0010","series-title":"Neonatal - Perinatal Medicine. Disease of the Fetus and Infant","first-page":"973","article-title":"Lung development and maturation","author":"Jobe","year":"2002"},{"issue":"8","key":"10.1016\/j.xphs.2021.12.004_bib0011","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/dmd.119.087163","article-title":"Plasma protein binding as an optimizable parameter for acidic drugs","volume":"47","author":"Gardiner","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2021.12.004_bib0012","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1183\/09031936.04.00106803","article-title":"Comparison of 99mTc-DTPA and urea for measuring cefepime concentrations in epithelial lining fluid","volume":"24","author":"Bayat","year":"2004","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.xphs.2021.12.004_bib0013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/bdd.767","article-title":"Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages","volume":"32","author":"Togami","year":"2011","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"10.1016\/j.xphs.2021.12.004_bib0014","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2133\/dmpk.18.319","article-title":"Distribution characteristics of grepafloxacin, a fluoroquinolone antibiotic, in lung epithelial lining fluid and alveolar macrophage","volume":"18","author":"Deguchi","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2021.12.004_bib0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejpb.2006.04.009","article-title":"Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats","volume":"64","author":"Sun","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2021.12.004_bib0016","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/jamp.2008.0689","article-title":"Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition","volume":"21","author":"Schmid","year":"2008","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"7","key":"10.1016\/j.xphs.2021.12.004_bib0017","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1128\/AAC.02818-14","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin","volume":"58","author":"Gontijo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.xphs.2021.12.004_bib0018","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/AAC.02819-14","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin","volume":"58","author":"Gontijo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.xphs.2021.12.004_bib0019","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1128\/AAC.00411-10","article-title":"Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats","volume":"54","author":"Marchand","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.xphs.2021.12.004_bib0020","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1183\/09031936.97.10102194","article-title":"Airway liquid: a barrier to drug diffusion?","volume":"10","author":"Widdicombe","year":"1997","journal-title":"Eur Respir J"},{"issue":"suppl 63","key":"10.1016\/j.xphs.2021.12.004_bib0021","first-page":"OA2103","article-title":"Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung \u2013 evaluation of regional lung targeting by direct sampling of epithelial lining fluid","volume":"54","author":"Sadiq","year":"2019","journal-title":"Eur Resp J"},{"key":"10.1016\/j.xphs.2021.12.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15621","article-title":"Lung pharmacokinetics of inhaled and systemic drugs: a clinical evaluation","author":"Sadiq","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2021.12.004_bib0023","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1164\/arrd.1987.135.6.1276","article-title":"Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage","volume":"135","author":"Marcy","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.xphs.2021.12.004_bib0024","first-page":"1517","article-title":"Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice","volume":"54","author":"Baxter","year":"1994","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.xphs.2021.12.004_bib0025","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.xphs.2017.03.038","article-title":"Physiologically based pharmacokinetic modeling of therapeutic proteins","volume":"106","author":"Wong","year":"2017","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:37:53Z","timestamp":1758361073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921006535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022354921006535"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.12.004","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible Extraction of Drugs from Lung Tissue During Broncho-alveolar Lavage Suggest Uncertainty in the Procedure's Utility for Quantitative Assessment of Airway Drug Exposure","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}